- Presentations
- 5
- Markets
- 1
Ayvakit is a brand of Avapritinib marketed by Blueprint Medicines, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Avapritinib
- Brand owner
- Blueprint Medicines
- Registered in
- United States
- Strengths and forms
- 100 mg tablet, 200 mg tablet, 25 mg tablet, 300 mg tablet, 50 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Ayvakit 100 mg tabletOral | Blueprint Medicines | US FDA | Available on request |
| Ayvakit 200 mg tabletOral | Blueprint Medicines | US FDA | Available on request |
| Ayvakit 25 mg tabletOral | Blueprint Medicines | US FDA | Available on request |
| Ayvakit 300 mg tabletOral | Blueprint Medicines | US FDA | Available on request |
| Ayvakit 50 mg tabletOral | Blueprint Medicines | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Ayvakit
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.